Michael Lachman brings 30 years of experience in medical technology, including consulting, investment research, business development, marketing, and engineering. His active involvement in the ophthalmology sector spans over 20 years.

 

Before launching EyeQ Research in 2005, Michael was a Partner, Managing Director, and equity research analyst with ThinkEquity Partners, a growth-focused investment bank based in San Francisco. At ThinkEquity, Michael's research was focused primarily on ophthalmic devices and pharmaceuticals, orthopedics, and specialty cardiology. Before that, Michael was a healthcare analyst on the buy-side with SAC Capital Advisors and Jurika & Voyles. His first experience in equity research was as a medical device analyst with Hambrecht & Quist, where he received a #1 ranking in medical industry stock picking in the Wall Street Journal All-Star Analyst Survey.

​

As a sell-side research analyst, Michael covered a broad range of eye care companies:

​

• Diversified Eye Care: Alcon, Advanced Medical Optics, Bausch + Lomb

• Refractive Surgery: VISX, Summit Autonomous, IntraLase, TLC Vision

• Retina: QLT, Eyetech Pharmaceuticals, OccuLogix

• Vision Care: Ocular Sciences

​

Michael also brings 12 years of medical device industry experience. He worked for five years in business development for the Ethicon Endo-Surgery division of Johnson & Johnson. Previously, Michael spent seven years with Baxter Healthcare Corporation, working in both research & development and product management, with a focus on implantable surgical products.

 

Michael holds an M.B.A. (with concentrations in marketing and finance) from Northwestern University's Kellogg School of Management. He also holds an M.S. in Mechanical Engineering from Stanford University. Michael received a B.S. in Aeronautical Engineering with highest honors from the University of Illinois.

 

E-mail: michael@lachmanconsulting.com